 |
 |

The Influence of Patient Adherence on Anticoagulation Control With WarfarinResults From the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
Stephen E. Kimmel, MD, MSCE;
Zhen Chen, PhD;
Maureen Price, RN;
Catherine S. Parker, MS;
Joshua P. Metlay, MD, PhD;
Jason D. Christie, MD, MSCE;
Colleen M. Brensinger, MS;
Craig W. Newcomb, MAR;
Frederick F. Samaha, MD;
Robert Gross, MD, MSCE
Arch Intern Med. 2007;167(3):229-235.
Background Warfarin sodium is a highly efficacious drug, but proper levels of anticoagulation are difficult to maintain. Conflicting data exist on the influence of patient adherence on anticoagulation control.
Methods We performed a prospective cohort study at 3 anticoagulation clinics to determine the effect of adherence on anticoagulation control. Patients treated with warfarin with a target international normalized ratio of 2.0 to 3.0 were monitored with electronic Medication Event Monitoring System (MEMS) medication bottle caps. Detailed information was collected on other factors that might alter warfarin response.
Results Among 136 participants observed for a mean of 32 weeks, 92% had at least 1 missed or extra bottle opening; 36% missed more than 20% of their bottle openings; and 4% had more than 10% extra bottle openings. In multivariable analyses, there was a significant association between underadherence and underanticoagulation. For each 10% increase in missed pill bottle openings, there was a 14% increase in the odds of underanticoagulation (P<.001); participants with more than 20% missed bottle openings (1-2 missed days each week) had more than a 2-fold increase in the odds of underanticoagulation (adjusted odds ratio, 2.10; 95% confidence interval, 1.48-2.96). Participants who had extra pill bottle openings on more than 10% of days had a statistically significant increase in overanticoagulation (adjusted odds ratio, 1.73; 95% confidence interval, 1.09-2.74).
Conclusion Patients have substantial difficulties maintaining adequate adherence with warfarin regimens, and this poor adherence has a significant effect on anticoagulation control.
Author Affiliations: Department of Medicine (Drs Kimmel, Metlay, Christie, Samaha, and Gross), Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics and Epidemiology (Drs Kimmel, Chen, Metlay, Christie, and Gross, Mss Price and Brensinger, and Mr Newcomb), University of Pennsylvania School of Medicine (Ms Parker), and Philadelphia Veterans Affairs Medical Center (Drs Metlay and Samaha), Philadelphia.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Comparison of Outcomes Among Patients Randomized to Warfarin Therapy According to Anticoagulant Control: Results From SPORTIF III and V
Harvey D. White, Michael Gruber, Jan Feyzi, Scott Kaatz, Hung-Fat Tse, Steen Husted, and Gregory W. Albers
Arch Intern Med. 2007;167(3):239-245.
ABSTRACT
| FULL TEXT
Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines
Nicole L. Glazer, Sascha Dublin, Nicholas L. Smith, Benjamin French, Lisa A. Jackson, Jennifer B. Hrachovec, David S. Siscovick, Bruce M. Psaty, and Susan R. Heckbert
Arch Intern Med. 2007;167(3):246-252.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Epidemiology of Subtherapeutic Anticoagulation in the United States
Rose et al.
Circ Cardiovasc Qual Outcomes 2009;2:591-597.
ABSTRACT
| FULL TEXT
Intensifying Therapy for Hypertension Despite Suboptimal Adherence
Rose et al.
Hypertension 2009;54:524-529.
ABSTRACT
| FULL TEXT
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
Witt et al.
Blood 2009;114:952-956.
ABSTRACT
| FULL TEXT
Effect of a Warfarin Adherence Aid on Anticoagulation Control in an Inner-City Anticoagulation Clinic Population
Nochowitz et al.
The Annals of Pharmacotherapy 2009;43:1165-1172.
ABSTRACT
| FULL TEXT
An update on cardioembolic stroke
Weir
Postgrad. Med. J. 2008;84:133-142.
ABSTRACT
| FULL TEXT
Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation
Anderson et al.
Circulation 2007;116:2563-2570.
ABSTRACT
| FULL TEXT
Warfarin Therapy in Clinical Practice
JWatch Neurology 2007;2007:2-2.
FULL TEXT
|